Kim Thomsen

Dr. Kim Thomsen

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2017 in APMIS
Verified
Journal Article
Closed access
PDF file
CMClaus Moser
Claus Moser
Hannah TrøstrupHannah Trøstrup
Hannah Trøstrup
CLChristian Johann Lerche
Christian Johann Lerche
MKMete Kolpen
Mete Kolpen
LLLaura Line
Laura Line
PJPeter Østrup Jensen
Peter Østrup Jensen

14 April 2019 in APMIS
Verified
Journal Article
Closed access
PDF file
CMClaus Moser
Claus Moser
CLChristian Johann Lerche
Christian Johann Lerche
KTKim Thomsen
Kim Thomsen
THTom Hartvig
Tom Hartvig
JSJens Schierbeck
Jens Schierbeck
NHNiels Høiby
Niels Høiby

25 February 2013 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
Hannah TrøstrupHannah Trøstrup
Hannah Trøstrup
KTKim Thomsen
Kim Thomsen
LCLars J. Christophersen
Lars J. Christophersen
HHHans P. Hougen
Hans P. Hougen
TBThomas Bjarnsholt
Thomas Bjarnsholt
CMClaus Moser
Claus Moser

18 March 2015 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
BCBao Cao
Bao Cao
LCLars Christophersen
Lars Christophersen
KTKim Thomsen
Kim Thomsen
MSMajken Sønderholm
Majken Sønderholm
TBThomas Bjarnsholt
Thomas Bjarnsholt
CMClaus Moser
Claus Moser
Treating biofilm infections successfully is a challenge. We hypothesized that biofilms may be considered as independent compartments with particular pharmacokinetics. We therefore studied the pharmacokinetics and pharmacodynamics of tobramycin in a seaweed alginate-embedded biofilm model. Seaweed alginate beads containing Pseudomonas aeruginosa were cultured in LB medium, sampled at day 1, 3, 5 or 7 and examined for the effect of treatment with tobramycin for 30 min. Treated beads were homogenized and the number of cfu was determined. The antibiotic concentration in the solution of homogenized beads was measured. Finally, beads were examined for live cells by Syto9 staining and for dead cells by propidium iodide staining using a confocal laser scanning microscope. The antibiotic level in each bead was relatively stable (range 30–42 mg/L; MIC = 1.5 mg/L). There were fewer cfu in the tobramycin-treated beads than the non-treated beads (P < 0.016) and bacterial killing was reduced as the culture period increased from 1 to 7 days. Throughout the study period, increasing size and more superficial positioning of the microcolonies within the beads were demonstrated by confocal laser scanning microscopy. More dead cells (measured by propidium iodide staining) were observed in the treated group of beads, which supports the results obtained by culture. The present study, simulating the clinical pharmacokinetics of tobramycin, demonstrates fast absorption of tobramycin in an in vitro biofilm model. In addition, this model system enables parallel investigation of pharmacokinetics and pharmacodynamics, providing a model for testing new treatment strategies.

1 September 2017 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
CLC.J. Lerche
C.J. Lerche
LCL.J. Christophersen
L.J. Christophersen
MKMete Kolpen
Mete Kolpen
PNP.R. Nielsen
P.R. Nielsen
Hannah TrøstrupHannah Trøstrup
Hannah Trøstrup
CMClaus Moser
Claus Moser

1 March 2016 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
KTKim Thomsen
Kim Thomsen
LCL. Christophersen
L. Christophersen
TBThomas Bjarnsholt
Thomas Bjarnsholt
PJPeter Østrup Jensen
Peter Østrup Jensen
CMC. Moser
C. Moser
NHNiels Høiby
Niels Høiby